Obese Males May Have Melanoma Survival Advantage


Obese metastatic melanoma patients who are treated using targeted or immunotherapies survive for up to twice as long as patients who have a normal body mass inde, according to U.S. scientists Source link

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close